Considering the importance of MLL3/4 in regulating enhancer transcription and gene expression, and their implication in various cancers and other diseases, it is of great interest to study how the PHD domains of MLL3/4 recognize histones and recruit the MLL3/4 methylation activity to the target chromatin regions. The gene discussed is KMT2C; the disease is cancer.